Medicine guide

abnobaVISCUM Fraxini 20 mg

As listed in the register: abnobaVISCUM Fraxini 20 mg, anthroposophisches Arzneimittel

20 mg ·

Active substance: Visci albi fraxini herbae recentis extractum liquidum (viscum album ssp. album L. + Herba; Wirtsbaum: Fraxinus excelsior L. + Fraxinus angustifolia Vahl oder ihre Hybriden)
Used in: Cancer treatments and immune-system medicines
Made by: Future Health Pharma GmbH
Source: Official label

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Gemäss der anthroposophischen Menschen- und Naturerkenntnis zur Zusatzbehandlung bei malignen Erkrankungen bei Erwachsenen

From the official label · 2026-09-30 · Swissmedic

Made by	Future Health Pharma GmbH
Active substance	Visci albi fraxini herbae recentis extractum liquidum (viscum album ssp. album L. + Herba; Wirtsbaum: Fraxinus excelsior L. + Fraxinus angustifolia Vahl oder ihre Hybriden)
Used in	Cancer treatments and immune-system medicines
Strength	20 mg
Classification	L01CX · Cancer treatments and immune-system medicines
Dispensing (as stated by the register)	Abgabekategorie A
Name in the register	abnobaVISCUM Fraxini 20 mg, anthroposophisches Arzneimittel
Packs	8 à 1ml Ampulle(n)
Zulassungsnummer	68315
Dosisstärke	1

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

These contain the same substance. That does not mean one can replace another — ask a pharmacist.